HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

OHI

Omega Healthcare Investors, Inc. (NYSE)

Real Estate — REIT - Healthcare Facilities

Omega Healthcare Investors, Inc. is a Real Estate Investment Trust. The firm is providing financing and capital to the long-term healthcare industry in the United States and the United Kingdom with a focus on skilled nursing and assisted living facilities, including care homes in the United Kingdom. As of September 30, 2025, Omega has a portfolio of investments that includes 1,024 operating facilities located in 42 states, the District of Columbia and the United Kingdom/Jersey (290 facilities) and operated by 88 different operators. Additionally, Omega has investments in several unconsolidated entities that own 19 facilities. As a source of capital to the healthcare industry, Omega continually evaluates the opportunities, trends and challenges affecting the industry. Our goal is to identify long-term investments in quality healthcare properties with outstanding operators that provide the most favorable risk/reward ratio to our investors. Omega Healthcare Investors, Inc. is based in Hunt Valley, United States.

Buy 2.3 / 5 17 analysts
$48.17
+$0.49 (+1.03%)
Target: $50.65 (5.1%)
Sign in to add OHI to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$15.02B
P/E Ratio (TTM)23.27
Forward P/E23.68
EPS (TTM)$2.07
Dividend Yield5.56%
Profit Margin51.41%
Revenue Growth14.30%
ROE12.63%
Debt/Equity81.51
Recommendation Buy 2.3
Analyst Target$50.65
Analysts17
Indexes NYSE

Technical Indicators

RSI (14)65.6
Beta0.58
SMA 20-
SMA 40-
52-Week High$49.33
52-Week Low$35.70
50-Day Avg$46.55
200-Day Avg$44.82
Avg Volume$2.37M
Volume$1.54M

Performance Analysis

BULLISH

OHI shows predominantly bullish signals based on its fundamentals and technicals.

- Trading near its 52-week high ($49.33), which may indicate limited upside.
+ RSI at 65.6 shows positive momentum.
+ Price is above both the 50-day and 200-day moving averages — strong uptrend.
~ Modest revenue growth of 14.3% year-over-year.
+ Healthy profit margin of 51.4%.
+ Wall Street consensus is "Buy" from 17 analysts.
+ Average analyst target of $50.65 implies 5.1% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:24 UTC

Back to Screener Export Report